Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

ANRS, Emerging Infectious Diseases

6 clinical trials · 6 recruiting · OTHER_GOV

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by ANRS, Emerging Infectious Diseases

RECRUITINGPhase 3NCT04145258

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

INTENSE-TBM is randomized controlled, phase III, multicenter, 2 x 2 factorial plan superiority trial assessing the efficacity of two interventions to reduce mortality from...

Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 76813 locations
Tuberculous Meningitis
RECRUITINGPhase 2NCT05590455

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Randomized phase II clinical trial which aims to assess the impact on 3-month mortality and safety of adding adalimumab to standard treatment (anti-tuberculosis drugs and...

Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 1303 locations
Tuberculous MeningitisHIV I Infection
RECRUITINGNCT05655702

DRug Use & Infections in ViEtnam: TuBerculosis Control

The overarching purpose of the proposed research is to demonstrate that a targeted, multi-component community-based intervention among PWID in Hai Phong will decrease TB...

Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 40002 locations
Tuberculosis
RECRUITINGPhase 3NCT05813964

Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.

The purpose of this study is to evaluate the efficacy, acceptability, and safety of a simplified event-driven pre-exposure prophylaxis of HIV based on oral TAF/FTC in...

Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 5244 locations
HIV/AIDS
RECRUITINGPhase 2NCT05300035

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

RHIVIERA-02 trial is a placebo-controlled double-blinded two arm prospective phase II trial. This study will test the use of broadly neutralising antibodies (bNAbs) in...

Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 6917 locations
HIV/AIDS and Infections
RECRUITINGNCT04166266

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

This is a multicentre observational study with prospective and retrospective data collection and retrospective data collection and biological collection from patients with HBV/HDV...

Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 80020 locations
Hepatitis D, ChronicHepatitis B, Chronic